Clinical Trial Update: Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

View source ↗

Summary

A clinical trial is evaluating intrathecal ziconotide for chemotherapy-induced peripheral neuropathy, and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Ziconotide (ziconotide)

Snippet

Sponsor: Christian Hospital Northeast Northwest | Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN) | Status: NOT_YET_RECRUITING